Start Schlagworte Biotech

Schlagwort: Biotech

Highlight 2025: ITM sichert sich bis zu 262,5 Mio. USD von...

0
2025 war ein Jahr voller Bewegung, neuer Impulse und wegweisender Entscheidungen. In unseren Highlights 2025 blicken wir zum Jahresende auf ausgewählte Beiträge und Gespräche...

BayOConnect 2026 – Forum for Biotech & LifeScience

0
Nach dem großen Erfolg der letzten beiden Jahre veranstaltet BioM die dritte Auflage der BayOConnect – Forum for Biotech & Life Sciences am 30. Juni...

26th Annual Biotech in Europe Forum

0
More information here!

BIO-Europe 2026

0
Join Europe's most inclusive biotech partnering event—November 9-11, 2026 BIO-Europe is expanding beyond traditional dealmaking to unite the full spectrum of biotech leadership—bringing regulatory, clinical,...

‘AI is no longer hype – it’s the new infrastructure of...

0
AI is transforming the life sciences from buzzword to backbone. From Göttingen to Munich, start-ups use it to accelerate drug discovery, boost precision, and even model...

‘We aim to set new standards in respiratory medicine with ATL-105’

0
AATec develops new therapeutics for inflammatory lung diseases based on a new recombinant version of alpha-1 antitrypsin. Backed by a pre-series A funding round...

BIOWEG erhält 16 Mio. EUR in Series-A-Runde

0
Das deutsche Biotech-Unternehmen Bioweg hat eine Series-A-Finanzierungsrunde über 16 Mio. EUR abgeschlossen. Angeführt wurde die Runde vom Axeleo Capital Green Tech Industry Fund, weitere...

25th Annual Biotech in Europe Forum

0
The 25th Annual Biotech in Europe Forum (#Sachs_BEF) will take place on the 8th - 9th of October 2025 at the Mövenpick Hotel Basel....

Biotech boom in Switzerland

0
The biotech sector is powering a strong first half year for the Swiss venture capital market. With CHF 705 million in invested capital, the...

Heading for clinical breakthrough backed by a broad investor base

0
Tubulis wants to improve the efficacy of cancer therapies by using antibody drug conjugates (ADCs). Three pipeline products are currently in clinical development. ‘We...

Handelsblatt Konferenz Biotech

0
From Science to Market: Business, Regulation & Investment Biotechnologie am Wendepunkt: Der geplante EU Biotech Act verspricht neue Impulse, doch die Branche fordert klare Regeln,...

Hightech meets animal health

0
The animal health market is booming – and it’s quickly emerging as an attractive investment opportunity for venture capital firms. Two portfolio companies backed by MIG...

Schweizer Start-up-Szene: 1,5 Mrd. CHF investiert

0
Trotz rückläufiger Dealzahlen verzeichnet die Schweiz mit 1,47 Mrd. CHF das drittbeste Halbjahresergebnis aller Zeiten – Highflyer und ein neues Unicorn sorgen für Rückenwind....

Nurturing biotech company creation

0
The focus of biotech company formation is primarily in the United States, followed by Europe, with Germany being well behind. This article examines the...

BIO-Europe®2025

0
BIO-Europe, Europe's premier biopharma partnering event, is heading to Vienna, Austria on November 3-5, 2025, followed by Digital Partnering on November 11-12. Drawing inspiration...